Episode Details
Back to Episodes
Episode 252: Talazoparib and its FDA approval in CRPC
Season 2
Episode 253
Published 3 years, 4 months ago
Description
Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs